Here, we hypothesized that NAC treatment may prevent THC-induced dysregulations in central redox signaling pathways linked to schizophrenia-related endophenotypes and mitigate impairments in social behaviour, cognitive deficits and sensorimotor gating, along with underlying aberrations in relevant neurotransmitter systems and electrophysiological parameters
J.LahmannC.LutherJ.ChungR
No Phase I, II, or III human clinical trials exist for BPC-157 as of 2026the peptide remains unregulated by the FDA and lacks validated dosing, safety, or efficacy data in human populations
Jurrus E, Engel D, Star K, Monson K, Brandi J, Felberg LE, et al
Learn More Adrian DArcy and Ashley Robinson spoke again at this years New Orleans Bar Associations Procrastinators Program